Brand against brand · teriparatide and abaloparatide

Forteo vs Tymlos

From the two FDA labels, read Published by PepVault

Forteo is teriparatide, a parathyroid hormone analog (PTH 1-34), from Eli Lilly; Tymlos is abaloparatide, a parathyroid hormone-related peptide analog (PTHrP 1-34), from Radius Health.

FDA approved Forteo for osteoporosis at high risk of fracture in women after menopause, in men, and in people on long-term steroid pills. Tymlos is approved for osteoporosis at high risk of fracture in women after menopause, and to raise bone density in men.

Label against label

Forteo and Tymlos, from their FDA labels and Drugs@FDA
ComparedForteoTymlos
Active ingredientteriparatideabaloparatide
Classparathyroid hormone analog (PTH 1-34)parathyroid hormone-related peptide analog (PTHrP 1-34)
MakerEli LillyRadius Health
Approved forOsteoporosis at high risk of fracture (women after menopause, men, steroid use)Osteoporosis at high risk of fracture (women after menopause, men)
FormsPrefilled penPrefilled pen
How oftenonce a dayonce a day
Starting dose20 mcg a day80 mcg a day
Top dose on the label20 mcg a day80 mcg a day
Most reported side effectPain, 21.3% on 20 mcg (placebo 20.5%)Calcium in the urine (hypercalciuria), 11% on 80 mcg (placebo 9%)
Boxed warningNoneNone
First approved20022017

Each label’s side-effect figure comes from its own trials, at its own doses and in its own patients; as the labels themselves say, rates from different trials can’t be compared directly.

The two dosing schedules

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

Forteo, once a day

One dose on the label: 20 mcg once a day.

Tymlos, once a day

One dose on the label: 80 mcg once a day.

A smiling woman in a dark training top in her kitchen, holding a glass of water

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

A missed dose, on each label

  • Forteo: Forteo’s label gives no instruction for a missed dose; a prescriber or pharmacist can answer for a given case.
  • Tymlos: Tymlos’s label gives no instruction for a missed dose; a prescriber or pharmacist can answer for a given case.

The trial evidence

Questions

What is the difference between Forteo and Tymlos?

Forteo is teriparatide, a parathyroid hormone analog (PTH 1-34); Tymlos is abaloparatide, a parathyroid hormone-related peptide analog (PTHrP 1-34). Their labels approve them for different uses and set different schedules.

What are Forteo and Tymlos approved for?

Forteo is approved for osteoporosis at high risk of fracture in women after menopause, in men, and in people on long-term steroid pills. Tymlos is approved for osteoporosis at high risk of fracture in women after menopause, and to raise bone density in men.

How often are Forteo and Tymlos taken?

Forteo is taken once a day, as an injection; Tymlos once a day, as an injection.

What are the dose ranges of Forteo and Tymlos?

On their labels, Forteo runs 20 mcg once a day, and Tymlos 80 mcg once a day. A prescriber sets the actual dose.

What is the most common side effect of Forteo and Tymlos?

On Forteo’s label: pain, 21.3% on 20 mcg (placebo 20.5%). On Tymlos’s: calcium in the urine (hypercalciuria), 11% on 80 mcg (placebo 9%).

Sources

PepVault is not affiliated with Eli Lilly. Forteo is a trademark of its owner. PepVault is not affiliated with Radius Health. Tymlos is a trademark of its owner.

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo